Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 22,388 | -197,878 | -528,628 | -652,172 | -746,354 |
| Depreciation Amortization | 4,054 | 3,356 | 2,081 | 28,928 | 3,648 |
| Accounts receivable | -101,279 | -58,484 | -198,715 | 2,375 | -10,103 |
| Accounts payable and accrued liabilities | 18,223 | 1,089 | 170 | 18,689 | 10,487 |
| Other Working Capital | -85,118 | -18,357 | -200,249 | -15,763 | -93,522 |
| Other Operating Activity | 187,059 | 182,408 | 330,606 | 104,198 | 272,718 |
| Operating Cash Flow | $45,327 | $-87,866 | $-594,735 | $-513,745 | $-563,126 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -313 | -403 | -674 | -1,524 | -1,103 |
| Purchase Of Investment | N/A | N/A | N/A | -331,863 | -171,281 |
| Sale Of Investment | N/A | N/A | N/A | 393,280 | 420,000 |
| Investing Cash Flow | $-313 | $-403 | $-674 | $59,893 | $247,616 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 365,454 | N/A | N/A | N/A |
| Common Stock Issued | 8,895 | 18,828 | 461,039 | 405,841 | 398,024 |
| Other Financing Activity | -11 | -235,041 | -66,540 | -40,182 | -5,788 |
| Financing Cash Flow | $8,884 | $149,241 | $394,499 | $365,659 | $392,236 |
| Exchange Rate Effect | 1,250 | -659 | 135 | -488 | -2,016 |
| Beginning Cash Position | 412,612 | 352,299 | 553,074 | 641,755 | 567,045 |
| End Cash Position | 467,760 | 412,612 | 352,299 | 553,074 | 641,755 |
| Net Cash Flow | $55,148 | $60,313 | $-200,775 | $-88,681 | $74,710 |
| Free Cash Flow | |||||
| Operating Cash Flow | 45,327 | -87,866 | -594,735 | -513,745 | -563,126 |
| Capital Expenditure | -313 | -403 | -773 | -1,524 | -1,103 |
| Free Cash Flow | 45,014 | -88,269 | -595,508 | -515,269 | -564,229 |